Alprazolam Tablet, Orally Disintegrating
FDA Label NDC 49884-111

52 label sections · Submitted to the FDA by Par Health Usa, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Par Health Usa, Llc for the product Alprazolam (NDC 49884-111). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: risks from concomitant use with opioids;  abuse, misuse, and addiction; and dependence and withdrawal reactions, 1.1 generalized anxiety disorder, 1.2 panic disorder, 2 dosage and administration, 2.1 generalized anxiety disorder, 2.2 panic disorder, 2.3 discontinuation or dosage reduction of alprazolam orally disintegrating tablets, 2.4 dosing in special populations, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.